CVRS - Corindus Vascular Robotics, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-9,6502,8422,729
Cost of Revenue-9,2654,9543,724
Gross Profit-385-2,112-995
Operating Expenses
Research Development-9,51710,31310,033
Selling General and Administrative-24,77719,52716,143
Non Recurring----
Total Operating Expenses-43,55934,79429,900
Operating Income or Loss--33,909-31,952-27,171
Income from Continuing Operations
Total Other Income/Expenses Net--214-1,126-1,592
Earnings Before Interest and Taxes--33,909-31,952-27,171
Interest Expense--208-1,001-1,592
Income Before Tax--34,123-33,078-28,763
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops--34,123-33,078-28,763
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--34,123-33,078-28,763
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--34,123-33,078-28,763